Taking people in Olaszország1. fázis
Study Evaluating the Safety, Efficacy, and Pharmacokinetics of Mosunetuzumab and a Combined Regimen of Mosunetuzumab and Venetoclax in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia
Key facts
- Where
- Brescia, Milan és Perugia, OlaszországSee the 4 sites
- Phase
- 1. fázis
Where in Olaszország
- Azienda Socio Sanitaria Territoriale degli Spedali Civili di BresciaBrescia, OlaszországTaking people
- ASST Grande Ospedale Metropolitano NiguardaMilan, OlaszországTaking people
- Ospedale San Raffaele S.r.l.Milan, OlaszországTaking people
- Hospital Santa Maria Della MisericordiaPerugia, OlaszországTaking people
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Trial details
- Who runs it
- F. Hoffmann-La Roche AG
- Trial code
- EU 2022-501876-24-00
- Record updated
- 2026. augusztus 3.